These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 30977891

  • 1. Clinical applications of Bioactive glass S53P4 in bone infections: a systematic review.
    Bigoni M, Turati M, Zanchi N, Lombardo AS, Graci J, Omeljaniuk RJ, Zatti G, Gaddi D.
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(2 Suppl):240-251. PubMed ID: 30977891
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of antibacterial bioactive glass S53P4 against S. aureus biofilms grown on titanium discs in vitro.
    Coraça-Huber DC, Fille M, Hausdorfer J, Putzer D, Nogler M.
    J Orthop Res; 2014 Jan; 32(1):175-7. PubMed ID: 24108602
    [Abstract] [Full Text] [Related]

  • 3. The Use of Bioactive Glass S53P4 as Bone Graft Substitute in the Treatment of Chronic Osteomyelitis and Infected Non-Unions - a Retrospective Study of 50 Patients.
    Malat TA, Glombitza M, Dahmen J, Hax PM, Steinhausen E.
    Z Orthop Unfall; 2018 Apr; 156(2):152-159. PubMed ID: 29665602
    [Abstract] [Full Text] [Related]

  • 4. Antimicrobial activity of bioactive glass S53P4 against representative microorganisms causing osteomyelitis - Real-time assessment by isothermal microcalorimetry.
    Gonzalez Moreno M, Butini ME, Maiolo EM, Sessa L, Trampuz A.
    Colloids Surf B Biointerfaces; 2020 May; 189():110853. PubMed ID: 32058256
    [Abstract] [Full Text] [Related]

  • 5. In vitro antibacterial activity of bioactive glass S53P4 on multiresistant pathogens causing osteomyelitis and prosthetic joint infection.
    Cunha MT, Murça MA, Nigro S, Klautau GB, Salles MJC.
    BMC Infect Dis; 2018 Apr 03; 18(1):157. PubMed ID: 29614973
    [Abstract] [Full Text] [Related]

  • 6. The in vitro antibacterial effect of S53P4 bioactive glass and gentamicin impregnated polymethylmethacrylate beads.
    Gergely I, Zazgyva A, Man A, Zuh SG, Pop TS.
    Acta Microbiol Immunol Hung; 2014 Jun 03; 61(2):145-60. PubMed ID: 24939683
    [Abstract] [Full Text] [Related]

  • 7. Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis.
    Lindfors NC, Hyvönen P, Nyyssönen M, Kirjavainen M, Kankare J, Gullichsen E, Salo J.
    Bone; 2010 Aug 03; 47(2):212-8. PubMed ID: 20624692
    [Abstract] [Full Text] [Related]

  • 8. Utilisation of bioactive glass S53P4 inside an induced membrane for severe bone defect with high risk of infection: a multi-center preliminary experience.
    Aurégan JC, Villain B, Glombitza M, Blokhuis T, Heinänen M, Bégué T.
    Injury; 2022 Oct 03; 53 Suppl 2():S13-S19. PubMed ID: 35871084
    [Abstract] [Full Text] [Related]

  • 9. Bioactive glass BAG-S53P4 for the adjunctive treatment of chronic osteomyelitis of the long bones: an in vitro and prospective clinical study.
    Drago L, Romanò D, De Vecchi E, Vassena C, Logoluso N, Mattina R, Romanò CL.
    BMC Infect Dis; 2013 Dec 10; 13():584. PubMed ID: 24325278
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bioactive glass S53P4 to fill-up large cavitary bone defect after acute and chronic osteomyelitis treated with antibiotic-loaded cement beads: A prospective case series with a minimum 2-year follow-up.
    Kojima KE, de Andrade E Silva FB, Leonhardt MC, de Carvalho VC, de Oliveira PRD, Lima ALLM, Roberto Dos Reis P, Silva JDS.
    Injury; 2021 Jul 10; 52 Suppl 3():S23-S28. PubMed ID: 34116851
    [Abstract] [Full Text] [Related]

  • 12. Clinical outcomes and complications of S53P4 bioactive glass in chronic osteomyelitis and septic non-unions: a retrospective single-center study.
    Gatti SD, Gaddi D, Turati M, Leone G, Arts JJ, Pessina F, Carminati M, Zatti G, De Rosa L, Bigoni M.
    Eur J Clin Microbiol Infect Dis; 2024 Mar 10; 43(3):489-499. PubMed ID: 38195783
    [Abstract] [Full Text] [Related]

  • 13. Bioactive glass for long bone infection: a systematic review.
    Aurégan JC, Bégué T.
    Injury; 2015 Dec 10; 46 Suppl 8():S3-7. PubMed ID: 26747915
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antimicrobial activity and resistance selection of different bioglass S53P4 formulations against multidrug resistant strains.
    Drago L, De Vecchi E, Bortolin M, Toscano M, Mattina R, Romanò CL.
    Future Microbiol; 2015 Dec 10; 10(8):1293-9. PubMed ID: 26228640
    [Abstract] [Full Text] [Related]

  • 17. Clinical Applications of S53P4 Bioactive Glass in Bone Healing and Osteomyelitic Treatment: A Literature Review.
    van Gestel NA, Geurts J, Hulsen DJ, van Rietbergen B, Hofmann S, Arts JJ.
    Biomed Res Int; 2015 Dec 10; 2015():684826. PubMed ID: 26504821
    [Abstract] [Full Text] [Related]

  • 18. S53P4 BIOACTIVE GLASS PUTTY IN THE LOCAL TREATMENT OF CAVITARY CHRONIC OSTEOMYELITIS.
    Reis GNBD, Cuba GT, Targa WHC, Miras PSC, Bongiovanni JC, Salles MJ, Reis FBD, Dell'aquila AM.
    Acta Ortop Bras; 2023 Dec 10; 31(1):e258453. PubMed ID: 36844131
    [No Abstract] [Full Text] [Related]

  • 19. Mid-term clinical results of chronic cavitary long bone osteomyelitis treatment using S53P4 bioactive glass: a multi-center study.
    Van Vugt TAG, Heidotting J, Arts JJ, Ploegmakers JJW, Jutte PC, Geurts JAP.
    J Bone Jt Infect; 2021 Dec 10; 6(9):413-421. PubMed ID: 34804776
    [Abstract] [Full Text] [Related]

  • 20. In vitro antibiofilm activity of bioactive glass S53P4.
    Drago L, Vassena C, Fenu S, De Vecchi E, Signori V, De Francesco R, Romanò CL.
    Future Microbiol; 2014 Dec 10; 9(5):593-601. PubMed ID: 24957087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.